Princeton to offer meningitis B vaccine to 6,000

Princeton University says a meningitis vaccine not yet licensed for use in the U.S. will be made available on campus starting Dec. 9 to nearly 6,000 students.

The Ivy League school has experienced an outbreak of type B meningococcal disease, which is sometimes life-threatening.

Seven Princeton students and one student visitor have been stricken by the bacterial illness since March.

Princeton said Tuesday that the U.S. Centers for Disease Control and Prevention has officially recommended all as well as graduate students living in dorms and the Graduate College and annexes receive the new vaccine. Vaccination is also recommended for employees with certain medical conditions.

The vaccine is licensed for use in Europe and Australia but not in the U.S. The Food and Drug Administration is allowing its use at Princeton.


Explore further

Princeton U. to give students meningitis B vaccine (Update 2)

© 2013 The Associated Press. All rights reserved.

Citation: Princeton to offer meningitis B vaccine to 6,000 (2013, November 26) retrieved 23 July 2019 from https://medicalxpress.com/news/2013-11-princeton-meningitis-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more